Environmental Health Research Department, National Institute of Environmental Research, Incheon, 22689, Republic of Korea.
National Cancer Control Institute, National Cancer Center, Goyang, 10408, Republic of Korea.
Chemosphere. 2023 May;322:138208. doi: 10.1016/j.chemosphere.2023.138208. Epub 2023 Feb 21.
Exposure to perfluoroalkyl substances (PFAS) may increase the risk of liver disease by disrupting cholesterol and lipid synthesis/metabolism, leading to higher liver-enzyme concentrations. However, most studies assessing association between PFAS and liver enzymes focused on individual PFAS. Moreover, PFAS concentrations differ based on sex and obesity status, and it remains unclear whether these factors affect associations with liver function. Therefore, we examined the association between exposure to both individual and combined PFAS and liver-function biomarkers and assessed sex and obesity as effect modifiers in Korean adults.
We measured serum concentrations of the five most abundant PFAS (PFOA, PFOS, PFHxS, PFDA, PFNA) and three liver enzymes (alanine transaminase [ALT], aspartate aminotransferase [AST], γ-glutamyl transferase [GGT]) in 1404 adults from the Korean National Environmental Health Survey Cycle 3, 2015-2017. We used linear regression to evaluate associations between individual PFAS and liver-function biomarkers, assessing sex and obesity as possible effect modifiers, and performed Bayesian kernel machine regression and quantile g-computation to evaluate the overall effect of PFAS mixture on biomarkers of liver function.
Among 1404 Korean adults, all five PFAS were detected. Geometric mean concentration was highest for PFOS (16.11 μg/L), followed by PFOA (5.83 μg/L), PFHxS (2.21 μg/L), PFNA (2.03 μg/L), and PFDA (1.06 μg/L). In multivariable linear regression, all PFAS were positively associated with ALT, AST, and GGT; 2-fold increase in each PFAS was associated with 3.4-8.6% higher ALT, 2.4-4.6% higher AST, and 4.6-11.1% higher GGT (all p < 0.05). Positive associations for PFOA, PFDA, and PFNA with AST were stronger in men, and positive associations for PFOS with ALT and GGT were stronger in women. Compared to obese participants, nonobese participants had higher average percent changes in each enzyme, particularly GGT, when individual PFAS concentration doubled. Additionally, increased exposure to PFAS mixtures was associated with higher ALT, AST, and GGT. In quantile g-computations, simultaneous quartile increase in all PFAS was significantly associated with 6.9% (95%CI: 3.7, 10.2) higher ALT, 4.5% (95%CI: 2.4, 6.6) higher AST, and 8.3% (95%CI: 3.7, 13.1) higher GGT levels, on average.
Exposure to individual and combined PFAS is associated with higher liver enzymes in Korean adults, providing additional evidence for the association between PFAS exposure and risk of liver disease.
全氟烷基物质(PFAS)暴露可能通过扰乱胆固醇和脂质的合成/代谢,导致更高的肝酶浓度,从而增加肝脏疾病的风险。然而,大多数评估 PFAS 与肝酶之间关联的研究都集中在单个 PFAS 上。此外,PFAS 浓度因性别和肥胖状况而异,目前尚不清楚这些因素是否会影响与肝功能的关联。因此,我们研究了暴露于个体和组合的 PFAS 与肝功能生物标志物之间的关联,并评估了性别和肥胖状况作为韩国成年人中可能的效应修饰物。
我们测量了 1404 名韩国成年人血清中五种最丰富的 PFAS(PFOA、PFOS、PFHxS、PFDA、PFNA)和三种肝酶(丙氨酸转氨酶[ALT]、天冬氨酸转氨酶[AST]、γ-谷氨酰转移酶[GGT])的浓度,这些成年人来自于 2015-2017 年韩国国家环境健康调查第三周期。我们使用线性回归来评估个体 PFAS 与肝功能生物标志物之间的关联,评估性别和肥胖状况作为可能的效应修饰物,并使用贝叶斯核机器回归和分位数 g 计算来评估 PFAS 混合物对肝功能生物标志物的总体影响。
在 1404 名韩国成年人中,所有五种 PFAS 均被检出。PFOS(16.11μg/L)的几何均数浓度最高,其次是 PFOA(5.83μg/L)、PFHxS(2.21μg/L)、PFNA(2.03μg/L)和 PFDA(1.06μg/L)。在多变量线性回归中,所有 PFAS 均与 ALT、AST 和 GGT 呈正相关;每种 PFAS 浓度增加两倍,与 ALT 升高 3.4%-8.6%、AST 升高 2.4%-4.6%和 GGT 升高 4.6%-11.1%相关(均 P<0.05)。PFOA、PFDA 和 PFNA 与 AST 的相关性在男性中更强,而 PFOS 与 ALT 和 GGT 的相关性在女性中更强。与肥胖参与者相比,非肥胖参与者在 PFAS 浓度加倍时,每种酶的平均百分比变化更高,尤其是 GGT。此外,PFAS 混合物暴露增加与 ALT、AST 和 GGT 升高有关。在分位数 g 计算中,所有 PFAS 的同时四分位增加与 ALT 升高 6.9%(95%CI:3.7,10.2)、AST 升高 4.5%(95%CI:2.4,6.6)和 GGT 升高 8.3%(95%CI:3.7,13.1)显著相关,平均而言。
暴露于个体和组合的 PFAS 与韩国成年人的肝酶升高有关,为 PFAS 暴露与肝脏疾病风险之间的关联提供了额外证据。